BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Boehringer Ingelheim Corporation Release: New Data Demonstrate Sustained Glucose Reduction and Weight Loss Up to 90 Weeks With Investigational SGLT-2 Inhibitor, Empagliflozin*

  June 11, 2012

   · 

  1 min read
• Drug Development

  Bristol-Myers Squibb Company and AstraZeneca PLC Release: New Data Show Investigational Compound Dapagliflozin Demonstrated Significant Reductions in Blood Sugar Levels When Added to Sitagliptin in Adults With Type 2 Diabetes at 24 Weeks, With Results Mai

  June 11, 2012

   · 

  1 min read
• Pharm Country

  Boehringer Ingelheim Corporation and Eli Lilly Canada Inc. Present New linagliptin Data at American Diabetes Association’s 72nd Scientific Sessions®

  June 11, 2012

   · 

  13 min read
• Business

  Governor Patrick Celebrates Grand Opening of New Thermo Fisher Scientific Facility in Tewksbury

  June 11, 2012

   · 

  2 min read
• Drug Development

  Halozyme Therapeutics, Inc. Release: Interim Data From Pre-administration of Hylenex in Analog Insulin Pump Therapy Demonstrate Consistent Insulin Action Profile: Data Presented in Late-Breaker Poster at American Diabetes Association 2012

  June 11, 2012

   · 

  5 min read
• Drug Development

  Novo Nordisk Release: Investigational Ultra Long-Acting Insulin Degludec Reduced Rates of Nocturnal Hypoglycemia in Type 2 Diabetes Patients Versus Insulin Glargine

  June 11, 2012

   · 

  4 min read
• Drug Development

  Sanofi (France) Release: Lyxumia® (lixisenatide) in Combination with Basal Insulin Plus Oral Anti-Diabetics Significantly Reduced HbA1c and Post-Prandial Glucose

  June 11, 2012

   · 

  9 min read
• Drug Development

  Ampio Pharmaceuticals, Inc. Release: Announces Positive Clinical Trial Results for the Treatment of Diabetic Macular Edema with Orally Administered Optina(TM)

  June 11, 2012

   · 

  6 min read
• Oxitec’s Genetic Technology Provides a New and Improved Approach to Controlling Cotton Pest Moth

  June 11, 2012

   · 

  2 min read
• Biotech Beach

  Fate Therapeutics And BD Biosciences Launch BD(TM) SMC4 to Improve Cellular Reprogramming and IPS Cell Culture Applications

  June 11, 2012

   · 

  4 min read